NFE2L2 and lung carcinoma: demonstrated that miR-155 mediates the Nuclear Factor Erythroid 2-related Factor 2(NRF2) signaling pathway by upregulating resistance to ATO in lung cancer cells; however, its downregulation can lead to increased cell apoptosis (99–101).